Shuklinova, O.; Wyszogrodzka-Gaweł, G.; Baran, E.; Lisowski, B.; Wiśniowska, B.; Dorożyński, P.; Kulinowski, P.; Polak, S.
Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets. Pharmaceutics 2024, 16, 259.
https://doi.org/10.3390/pharmaceutics16020259
AMA Style
Shuklinova O, Wyszogrodzka-Gaweł G, Baran E, Lisowski B, Wiśniowska B, Dorożyński P, Kulinowski P, Polak S.
Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets. Pharmaceutics. 2024; 16(2):259.
https://doi.org/10.3390/pharmaceutics16020259
Chicago/Turabian Style
Shuklinova, Olha, Gabriela Wyszogrodzka-Gaweł, Ewelina Baran, Bartosz Lisowski, Barbara Wiśniowska, Przemysław Dorożyński, Piotr Kulinowski, and Sebastian Polak.
2024. "Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets" Pharmaceutics 16, no. 2: 259.
https://doi.org/10.3390/pharmaceutics16020259
APA Style
Shuklinova, O., Wyszogrodzka-Gaweł, G., Baran, E., Lisowski, B., Wiśniowska, B., Dorożyński, P., Kulinowski, P., & Polak, S.
(2024). Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets. Pharmaceutics, 16(2), 259.
https://doi.org/10.3390/pharmaceutics16020259